(Q53427707)

14 May 2018

title

Application of immunosignatures to the assessment of Alzheimer's disease. (English)

1 reference

14 May 2018

author name string

Lucas Restrepo

1

1 reference

14 May 2018

Phillip Stafford

2

1 reference

14 May 2018

D Mitch Magee

3

1 reference

14 May 2018

Stephen Albert Johnston

4

1 reference

14 May 2018

publication date

1 August 2011

1 reference

14 May 2018

published in

Annals of Neurology

1 reference

14 May 2018

volume

70

1 reference

14 May 2018

issue

2

1 reference

14 May 2018

page(s)

286-295

1 reference

14 May 2018

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

cites work

1 reference

Clinical practice. Early Alzheimer's disease

21 January 2018

1 reference

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

21 January 2018

1 reference

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

Immune response to Abeta-peptides in peripheral blood from patients with Alzheimer's disease and control subjects

21 January 2018

1 reference

Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease.

21 January 2018

1 reference

Reduced levels of amyloid beta-peptide antibody in Alzheimer disease

21 January 2018

1 reference

Human anti-beta-amyloid antibodies block beta-amyloid fibril formation and prevent beta-amyloid-induced neurotoxicity

21 January 2018

1 reference

Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies

21 January 2018

1 reference

Autoantibodies to neurofibrillary tangles and brain tissue in Alzheimer's disease. Establishment of Epstein-Barr virus-transformed antibody-producing cell lines

21 January 2018

1 reference

Serum autoantibodies in patients with Alzheimer's disease and vascular dementia and in nondemented control subjects

21 January 2018

1 reference

Autoantibodies to redox-modified oligomeric Abeta are attenuated in the plasma of Alzheimer's disease patients

21 January 2018

1 reference

Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides

21 January 2018

1 reference

Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development

21 January 2018

1 reference

Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis

21 January 2018

1 reference

Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer's disease and healthy subjects.

21 January 2018

1 reference

Range of antinuclear antibodies in "healthy" individuals

21 January 2018

1 reference

Peptide microarrays for carbohydrate recognition.

21 January 2018

1 reference

Bacterial glycoprofiling by using random sequence peptide microarrays

21 January 2018

1 reference

Creating protein affinity reagents by combining peptide ligands on synthetic DNA scaffolds

21 January 2018

1 reference

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

Three methods for optimization of cross-laboratory and cross-platform microarray expression data

21 January 2018

1 reference

Strong feature sets from small samples.

21 January 2018

1 reference

Animal models of Alzheimer's disease and frontotemporal dementia

21 January 2018

1 reference

Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease

21 January 2018

1 reference

Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice.

21 January 2018

1 reference

Clustal W and Clustal X version 2.0

21 January 2018

1 reference

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening

21 January 2018

1 reference

Fishing for biomarkers with antigen mimics

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.22405

1 reference

14 May 2018

1 reference

14 May 2018